Aromatase & estrogen management
One of 5 mechanistic pathways to ⚡ Testosterone & the male hormonal axis · 11 options
Testosterone converts to estradiol via aromatase, mostly in fat tissue. Men need estradiol — for libido, bone, lipids and mood — so this is a U-shaped curve and not a lower-is-better one. More harm is done here by overcorrection than by high estrogen.
Use the sensitive (LC-MS/MS) assay — the standard immunoassay is unreliable at male levels and has driven more unnecessary aromatase-inhibitor use than anything else. More harm is done here by overcorrection than by high estrogen.
Estradiol, Sensitive (LC/MS-MS)Total TestosteroneSHBG (Sex Hormone-Binding Globulin)Lipid Panel (Cholesterol, HDL, LDL, Triglycerides)🔄 TRT Monitoring covers these in one panel →
What engages this pathway
Ordered by how directly each one acts on the mechanism above — never by how much trial evidence exists. Each links to its full breakdown with dosing, half-life and vendor.
💉 Anastrozole
A reversible aromatase inhibitor. Effective and very easy to overshoot — crashed estradiol produces joint pain, no libido, depression and accelerated bone loss, and it feels exactly like the problem you were treating.
💉 Exemestane
A suicidal (irreversible) aromatase inactivator, so no rebound on discontinuation. Slightly androgenic itself and generally less prone to overshoot than anastrozole.
💉 Raloxifene
A SERM that blocks estrogen at breast tissue while preserving bone effects. Better evidence than tamoxifen for established gynecomastia.
💉 Tamoxifen
Blocks estrogen at breast tissue. First-line for acute gynecomastia and, unlike an AI, does not lower systemic estradiol.
🧬 DIM
Shifts estrogen metabolism toward the 2-hydroxy pathway and away from the 16-hydroxy one — changing which metabolites you make rather than how much estrogen you have. A meaningfully different and gentler intervention than aromatase inhibition.
🧬 Indole-3-Carbinol (I3C)
The precursor DIM is made from in stomach acid. Conversion is variable, which is why DIM is usually preferred.
🧬 Calcium D-Glucarate
Inhibits beta-glucuronidase in the gut, so conjugated estrogens stay conjugated and get excreted rather than reabsorbed. Elimination rather than production — an under-used angle.
🧬 Chrysin
An aromatase inhibitor in vitro with famously poor oral bioavailability. The in-vitro result is real and rarely survives contact with your digestive tract.
🧬 Grape Seed Extract
Procyanidins inhibit aromatase in cell models.
🧬 Zinc
Mild aromatase inhibition alongside its role in testosterone synthesis.
🧬 Boron
Raises free testosterone and lowers estradiol modestly in small human studies.
The other 4 routes to testosterone & the male hormonal axis
Pick the pathway that matches where you are actually stuck. An appetite drug does nothing for someone who already undereats.
Want the protocols behind these?
Dosing schedules, stacking, cycle timing and Coach Cam's notes live inside the Academy — plus the full interactive Vault.
Join the Academy — $10/mo →← Open this pathway in the interactive Vault
Frequently asked questions
Testosterone converts to estradiol via aromatase, mostly in fat tissue. Men need estradiol — for libido, bone, lipids and mood — so this is a U-shaped curve and not a lower-is-better one. More harm is done here by overcorrection than by high estrogen.
11 options are mapped to this pathway in the Vault, including Anastrozole, Exemestane, Raloxifene, Tamoxifen. They are grouped by the mechanism they act through rather than ranked by how much trial evidence exists — 7 carry clinical validation and 4 are mechanistic predictions.
Use the sensitive (LC-MS/MS) assay — the standard immunoassay is unreliable at male levels and has driven more unnecessary aromatase-inhibitor use than anything else. More harm is done here by overcorrection than by high estrogen. The markers worth checking are Estradiol, Sensitive (LC/MS-MS), Total Testosterone, SHBG (Sex Hormone-Binding Globulin), Lipid Panel (Cholesterol, HDL, LDL, Triglycerides).
Unproven is not the same as ineffective. Of the 11 options on this pathway, 7 have clinical validation and 4 are graded theoretical — meaning the mechanism is sound but the specific human trial has not been run, which is true of a great deal of what works in this space. Nothing on this page is ordered by evidence tier, because sorting by trial count would bury the compounds you came looking for.